These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18563954)

  • 1. Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.
    Pea F; Pavan F; Furlanut M
    Clin Pharmacokinet; 2008; 47(7):449-62. PubMed ID: 18563954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
    Pea F; Furlanut M
    Clin Pharmacokinet; 2001; 40(11):833-68. PubMed ID: 11735605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.
    Matzke GR; Frye RF
    Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to measure pharmacokinetics in critically ill patients?
    Liu X; Kruger PS; Roberts MS
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2037-43. PubMed ID: 21554213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.
    van den Broek MP; Groenendaal F; Egberts AC; Rademaker CM
    Clin Pharmacokinet; 2010 May; 49(5):277-94. PubMed ID: 20384391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
    Anderson GD
    Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of drugs used in critically ill adults.
    Power BM; Forbes AM; van Heerden PV; Ilett KF
    Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
    Singh J; Burr B; Stringham D; Arrieta A
    Paediatr Drugs; 2001; 3(10):733-61. PubMed ID: 11706924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover.
    Qian CQ; Zhao KJ; Chen Y; Liu L; Liu XD
    Eur J Pharm Sci; 2019 Jun; 134():194-204. PubMed ID: 31047967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges.
    Kumta N; Roberts JA; Lipman J; Wong WT; Joynt GM; Cotta MO
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.